Obsidian Therapeutics, Inc. Share Price
NASDAQ: OBXObsidian Therapeutics, Inc. Stock Performance
Obsidian Therapeutics, Inc. Share Price Today
As of 5 October 2026, Obsidian Therapeutics, Inc.'s share price is $13.66. The stock opened at $13.41, compared to its previous close of $13.34. During today's trading session, Obsidian Therapeutics, Inc.'s share price traded between $13.30 and $13.74, with an average price of $13.52. Over the past 52 weeks, the stock has recorded a high of $36.16 and a low of $12.21. In terms of performance, Obsidian Therapeutics, Inc.'s share price has declined by 21.01% over the last six months and is down 21.01% on a year-on-year basis.
Obsidian Therapeutics, Inc. Share Price Chart
About Obsidian Therapeutics, Inc.
Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.
Obsidian Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $14.10 | $13.68 | -0.69% |
Sep 2026 | $17.21 | $13.78 | -20.38% |
Aug 2026 | $28.49 | $17.30 | N/A |